Compare LSCC & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSCC | EHC |
|---|---|---|
| Founded | 1983 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Hospital/Nursing Management |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 10.7B |
| IPO Year | 1994 | 1994 |
| Metric | LSCC | EHC |
|---|---|---|
| Price | $108.27 | $105.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 7 |
| Target Price | $102.08 | ★ $143.29 |
| AVG Volume (30 Days) | ★ 1.3M | 849.0K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | N/A | ★ 24.22 |
| EPS | 0.02 | ★ 5.54 |
| Revenue | ★ $385,961,000.00 | N/A |
| Revenue This Year | $35.79 | $9.35 |
| Revenue Next Year | $19.93 | $8.15 |
| P/E Ratio | $5,543.00 | ★ $19.24 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $39.60 | $92.77 |
| 52 Week High | $111.65 | $127.99 |
| Indicator | LSCC | EHC |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 55.34 |
| Support Level | $82.20 | $94.47 |
| Resistance Level | $108.08 | $109.14 |
| Average True Range (ATR) | 4.77 | 2.55 |
| MACD | 1.48 | 0.92 |
| Stochastic Oscillator | 85.76 | 69.93 |
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.